Shimatsu, Akira, et al. “OSILODROSTAT IS EFFECTIVE AND WELL- TOLERATED IN ASIAN AND NON-ASIAN PATIENTS WITH CUSHING’S DISEASE: RESULTS FROM LINC 3 (PHASE III STUDY)”. Journal of the ASEAN Federation of Endocrine Societies, vol. 37, no. 2, Oct. 2022, pp. 75-76, doi:10.15605/jafes.037.AFES.118.